Clinical case of Guillain-Barré syndrome associated with COVID-19
Open Access
- 23 July 2021
- journal article
- research article
- Published by ECO-Vector LLC in Journal of Clinical Practice
- Vol. 12 (2) , 110-118
Abstract
Background: The coronavirus infection caused by SARS-Cov-2 is characterized by a damage to many organs and systems of the human body. To date, convincing information has been obtained about the involvement of various parts of the nervous system in the pathological process in patients with COVID-19. Among the most frequently described impairments, there are disorders of smell and taste, common disorders of the central nervous system, characterized by general cerebral symptoms, such as headache, asthenization, psychopathological disorders. One of the rare and severe forms of the peripheral nervous system damage in COVID-19 is Guillain-Barre syndrome (GBS), characterized by acute post-infectious inflammatory polyneuropathy with an autoimmune etiology. Clinical case description. We present a clinical case of GBS associated with COVID-19. The disease debuted as a peripheral tetraparesis with a progredient course of up to 21 days. Systemic administration of immunoglobulin stopped the disease progression. The association of GBS with COVID-19 was clarified a month after the disease onset, when bilateral polysegmental pneumonia was diagnosed, and a high level of IgG to the S-protein of SARS-CoV-2 was found, 3 times higher than the level of IgM, which indicated the duration of the disease was not less than three weeks. Conclusion: The GBS development upon infection with SARS-CoV-2 may precede the lung damage. The debut of GBS during the COVID-19 pandemic requires the exclusion of the SARS-CoV-2 etiological role in each case.Keywords
This publication has 18 references indexed in Scilit:
- Miller Fisher syndrome and polyneuritis cranialis in COVID-19Neurology, 2020
- COVID‐19–associated Guillain‐Barré syndrome: The early pandemic experienceMuscle & Nerve, 2020
- THE NERVOUS SYSTEM DAMAGE IN COVID-19 PATIENTSJournal of Clinical Practice, 2020
- PULMONARY PATHOLOGY OF NEW CORONAVIRUS DISEASE (COVID- 19). THE PRELIMINARY ANALYSIS OF POST-MORTEM FINDINGSJournal of Clinical Practice, 2020
- Guillain–Barré Syndrome Associated with SARS-CoV-2New England Journal of Medicine, 2020
- Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence?The Lancet Neurology, 2020
- COVID-19. Etiology, pathogenesis, diagnosis and treatmentJournal of Clinical Practice, 2020
- Guillain–Barre SyndromeSeminars in Neurology, 2019
- Diagnosis and management of Guillain–Barré syndrome in ten stepsNature Reviews Neurology, 2019
- Guillain-Barré syndromeThe Lancet, 2016